SynCore Biotechnology Co.,Ltd

Research SynCore Biotechnology Co.,Ltd (4192.TWO) on Bullrun: market cap TWD 640.00M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker4192.TWO
ExchangeTWO
CountryTaiwan
SectorHealthcare
IndustryBiotechnology
CurrencyTWD
Market capTWD 640.00M
Financial periodQ2 2026
RevenueTWD 6.28M
Net income-TWD 13.46M
Free cash flow-TWD 8.08M
Gross margin68.4%

Valuation Snapshot

latest market cap is TWD 640.00M.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	TWD 640.00M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About SynCore Biotechnology Co.,Ltd

SynCore Biotechnology Co.,Ltd, engages in development and sale of healthy food, medicine inspection, and biotechnology service in Taiwan. The company is involved in the development of SB01, an injectable anti-cancer new ingredient (NCE) that is in Phase II clinical trials for the treatment of head and neck cancer; and SB02, an anti-cancer NCE, which is in preclinical research for use in the treatment of stomach cancer.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Synbio Tech Inc. (1295.TWO) Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) Level Biotechnology Inc. (3118.TWO) GenMont Biotech Incorporation (3164.TW) Medigen Biotechnology Corp. (3176.TWO) Sagittarius Life Science Corp (3205.TWO) NeoCore Technology Co., Ltd. (4131.TWO) Abnova (Taiwan) Corporation (4133.TW) Adimmune Corporation (4142.TW) TaiMed Biologics Inc. (4147.TWO)

Frequently asked questions

What is SynCore Biotechnology Co.,Ltd's market cap?

SynCore Biotechnology Co.,Ltd's market capitalization is TWD 640.00M.